Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

Hamdy FC. et al, (2023), New England Journal of Medicine

Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment

Donovan JL. et al, (2023), NEJM Evidence

Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole genome sequencing with histopathological features

Rao SR. et al, (2023)

Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival.

Whitburn J. et al, (2022), Sci Adv, 8

Local anaesthetic transperineal (LATP) prostate biopsy using a probe-mounted transperineal access system: a multicentre prospective outcome analysis.

Lopez JF. et al, (2021), BJU Int, 128, 311 - 318

Placebo comparator group selection and use in surgical trials: the ASPIRE project including expert workshop.

Beard DJ. et al, (2021), Health Technol Assess, 25, 1 - 52

Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer.

Sjoberg HT. et al, (2021), Br J Cancer, 125, 534 - 546

Applying Surgical Placebo in Randomised Evaluations (ASPIRE) - methods and recommendations for placebo comparator group selection and use in surgical trials

BEARD D. et al, (2021), NIHR Journals Library

A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal Disease.

Erickson A. et al, (2021), Eur Urol Oncol, 4, 358 - 369

Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic Review.

Farolfi A. et al, (2021), Eur Urol Oncol

Use of intraoperative fluorescence to enhance robot-assisted radical prostatectomy.

Rajakumar T. et al, (2021), Future Oncol, 17, 1083 - 1095

Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.

Huynh-Le M-P. et al, (2021), Nat Commun, 12

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

Conti DV. et al, (2021), Nat Genet, 53, 65 - 75

Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.

Bailey MH. et al, (2020), Nat Commun, 11

Outreach and Influence of Surgical Societies' Recommendations on Minimally Invasive Surgery During the COVID-19 Pandemic-An Anonymized International Urologic Expert Inquiry.

Boehm K. et al, (2020), Urology, 145, 73 - 78

Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial.

Sanghera S. et al, (2020), BMC Cancer, 20

The effect of sample size on polygenic hazard models for prostate cancer.

Karunamuni RA. et al, (2020), Eur J Hum Genet, 28, 1467 - 1475

Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.

Bailey MH. et al, (2020), Nat Commun, 11

Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial.

Wade J. et al, (2020), BMJ Open, 10

A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data.

Huynh-Le M-P. et al, (2020), Cancer Epidemiol Biomarkers Prev, 29, 1731 - 1738

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?